VICP Registry Case Source Bundle
Canonical URL: https://vicp-registry.org/case/USCOURTS-cofc-1_22-vv-01291
Package ID: USCOURTS-cofc-1_22-vv-01291
Petitioner: Jama Dilbeck
Filed: 2022-09-14
Decided: 2023-09-25
Vaccine: influenza
Vaccination date: 2020-10-08
Condition: Guillain-Barre Syndrome (“GBS”)
Outcome: entitlement_granted_pending_damages
Award amount USD: 

AI-assisted case summary:
Jama Dilbeck filed a petition for compensation under the National Vaccine Injury Compensation Program on September 14, 2022, alleging she received an influenza vaccine on October 8, 2020, and subsequently developed Guillain-Barre Syndrome (GBS). She stated the vaccine was administered in the United States, her injury had residual effects for more than six months, and she had not received prior compensation. Respondent, the Secretary of Health and Human Services, filed a Rule 4(c) report on August 22, 2023. In this report, Respondent conceded that Petitioner is entitled to compensation, agreeing that she met the criteria for GBS as set forth in the Vaccine Injury Table and the Qualifications and Aids to Interpretation, and that she satisfied the statutory severity requirements. Based on Respondent's concession and the evidence, Chief Special Master Corcoran found Petitioner entitled to compensation, with the case proceeding to damages.

Theory of causation field:
Table

Public staged source text:

================================================================================
DOCUMENT 1: USCOURTS-cofc-1_22-vv-01291-0
Date issued/filed: 2023-09-25
Pages: 2
Docket text: PUBLIC ORDER/RULING (Originally filed: 08/22/2023) regarding 28 Ruling on Entitlement. Signed by Chief Special Master Brian H. Corcoran. (kle) Service on parties made.
--------------------------------------------------------------------------------
Case 1:22-vv-01291-UNJ Document 31 Filed 09/25/23 Page 1 of 2
In the United States Court of Federal Claims
OFFICE OF SPECIAL MASTERS
No. 22-1291V
JAMA DILBECK, Chief Special Master Corcoran
Petitioner, Filed: August 22, 2023
v.
SECRETARY OF HEALTH AND
HUMAN SERVICES,
Respondent.
Renee J. Gentry, The Law Office of Renee J. Gentry, Washington, DC, for Petitioner.
Parisa Tabassian, U.S. Department of Justice, Washington, DC, for Respondent.
RULING ON ENTITLEMENT1
On September 14, 2022, Jama Dilbeck filed a petition for compensation under the
National Vaccine Injury Compensation Program, 42 U.S.C. §300aa-10, et seq.2 (the
“Vaccine Act”). Petitioner alleges that she received an influenza vaccine on October 8,
2020 and suffered Guillain-Barre Syndrome (“GBS”) thereafter. Petition at 1. Petitioner
further alleges that the vaccine was administered within the United States, that she
suffered the residual effects of her injury for more than six months, and that she has not
received any compensation in the form of an award or settlement for her vaccine-related
injury. Petition at 8. The case was assigned to the Special Processing Unit of the Office
of Special Masters.
1 Because this Ruling contains a reasoned explanation for the action taken in this case, it must be made
publicly accessible and will be posted on the United States Court of Federal Claims' website, and/or
at https://www.govinfo.gov/app/collection/uscourts/national/cofc, in accordance with the E-Government
Act of 2002. 44 U.S.C. § 3501 note (2018) (Federal Management and Promotion of Electronic Government
Services). This means the Ruling will be available to anyone with access to the internet. In accordance
with Vaccine Rule 18(b), Petitioner has 14 days to identify and move to redact medical or other information,
the disclosure of which would constitute an unwarranted invasion of privacy. If, upon review, I agree that
the identified material fits within this definition, I will redact such material from public access.
2 National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755. Hereinafter, for ease
of citation, all section references to the Vaccine Act will be to the pertinent subparagraph of 42 U.S.C. §
300aa (2018).

Case 1:22-vv-01291-UNJ Document 31 Filed 09/25/23 Page 2 of 2
On August 22, 2023, Respondent filed his Rule 4(c) report in which he concedes
that Petitioner is entitled to compensation in this case. Respondent’s Rule 4(c) Report at
1. Specifically, Respondent has concluded that Petitioner has satisfied the criteria for
GBS set forth in the Vaccine Injury Table and the Qualifications and Aids to Interpretation.
Id. at 8. Respondent further agrees that Petitioner has satisfied the statutory severity
requirements of the Vaccine Act. Id.
In view of Respondent’s position and the evidence of record, I find that
Petitioner is entitled to compensation.
IT IS SO ORDERED.
s/Brian H. Corcoran
Brian H. Corcoran
Chief Special Master
2